| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 09/05/2024 | 22:23 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:EVH | Evolent Health Inc |
| 09/05/2024 | 22:15 | PR Newswire (US) | Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S. | NYSE:EVH | Evolent Health Inc |
| 09/05/2024 | 22:10 | PR Newswire (US) | Evolent Announces First Quarter 2024 Results | NYSE:EVH | Evolent Health Inc |
| 18/04/2024 | 22:30 | PR Newswire (US) | Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 | NYSE:EVH | Evolent Health Inc |
| 06/03/2024 | 01:24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:EVH | Evolent Health Inc |
| 26/02/2024 | 22:59 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NYSE:EVH | Evolent Health Inc |
| 23/02/2024 | 12:52 | Edgar (US Regulatory) | Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers | NYSE:EVH | Evolent Health Inc |
| 22/02/2024 | 22:10 | PR Newswire (US) | Evolent Announces Fourth Quarter and Full Year 2023 Results | NYSE:EVH | Evolent Health Inc |
| 14/02/2024 | 22:10 | PR Newswire (US) | Evolent Adds Russell Glass, Headspace CEO, to Board of Directors | NYSE:EVH | Evolent Health Inc |
| 25/01/2024 | 13:00 | PR Newswire (US) | Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024 | NYSE:EVH | Evolent Health Inc |
| 06/12/2023 | 04:59 | PR Newswire (US) | Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan | NYSE:EVH | Evolent Health Inc |
| 05/12/2023 | 22:19 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:EVH | Evolent Health Inc |
| 05/12/2023 | 16:30 | Dow Jones News | Evolent Health Shares Drop on $350 Million Note Offering | NYSE:EVH | Evolent Health Inc |
| 05/12/2023 | 13:00 | PR Newswire (US) | Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan | NYSE:EVH | Evolent Health Inc |
| 03/11/2023 | 13:53 | Edgar (US Regulatory) | Form 424B7 - Prospectus [Rule 424(b)(7)] | NYSE:EVH | Evolent Health Inc |
| 02/11/2023 | 22:18 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NYSE:EVH | Evolent Health Inc |
| 02/11/2023 | 21:10 | PR Newswire (US) | Evolent Announces Third Quarter 2023 Results | NYSE:EVH | Evolent Health Inc |
| 10/10/2023 | 23:30 | PR Newswire (US) | Evolent to release third quarter financial results on Thursday, Nov. 2, 2023, and participate in upcoming investor conferences | NYSE:EVH | Evolent Health Inc |
| 26/09/2023 | 23:28 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NYSE:EVH | Evolent Health Inc |
| 24/08/2023 | 23:21 | PR Newswire (US) | Evolent saves Medicare more than $55 million through its Medicare Shared Savings Program ACO | NYSE:EVH | Evolent Health Inc |
| 08/08/2023 | 23:00 | PR Newswire (US) | Evolent Health to Participate in Upcoming Conferences | NYSE:EVH | Evolent Health Inc |
| 02/08/2023 | 22:10 | PR Newswire (US) | Evolent Announces Second Quarter 2023 Results | NYSE:EVH | Evolent Health Inc |
| 26/07/2023 | 22:42 | PR Newswire (US) | Evolent welcomes Toyin Ajayi to its Board of Directors | NYSE:EVH | Evolent Health Inc |
| 13/07/2023 | 22:15 | PR Newswire (US) | Evolent to Release Second Quarter Financial Results on Wednesday, August 2, 2023 | NYSE:EVH | Evolent Health Inc |
| 11/07/2023 | 15:00 | PR Newswire (US) | Evolent Health announces focus on value-based specialty care with rebrand, unification of all solutions under "Evolent" | NYSE:EVH | Evolent Health Inc |
| 16/06/2023 | 22:40 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:EVH | Evolent Health Inc |
| 14/06/2023 | 18:04 | Edgar (US Regulatory) | Report of Proposed Sale of Securities (144) | NYSE:EVH | Evolent Health Inc |
| 08/06/2023 | 22:16 | Edgar (US Regulatory) | Current Report Filing (8-k) | NYSE:EVH | Evolent Health Inc |
| 08/05/2023 | 22:58 | Edgar (US Regulatory) | Amended Report of Proposed Sale of Securities (144/a) | NYSE:EVH | Evolent Health Inc |
| 04/05/2023 | 12:07 | Edgar (US Regulatory) | Quarterly Report (10-q) | NYSE:EVH | Evolent Health Inc |